Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Cited by
Items 301–400 of 1,000
Kuo, F., Tsai, H.-Y., Cheng, B.-L., Tsai, K.-J., Chen, P., Huang, Y., Liu, C., Wu, D., Wu, M., Huang, B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031857 · Cited by 27
“10– TGF-β 13,34].”
BackgroundHua, F., Chi, X., Wang, M., Liu, J., Sun, M., Zhang, J., & Zhang, W. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05161-3 · Cited by 29
“As an important component of the tumor microenvironment (TME), tumor-associated macrophages (TAMs) have been reported to play essential roles in a variety of biological functions [6].”
Tumor‐Associated Macrophages: Key Players in the Non‐Small Cell Lung Cancer Tumor Microenvironment
Lv, T., Fan, R., Wu, J., Gong, H., Gao, X., Liu, X., Gong, Y., Luo, B., Zhang, Y., Peng, X., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70670 · Cited by 33
“M2 macrophages are often anti-inflammatory in nature, secreting low levels of IL-12 and high levels of IL-10 [18].”
New power in cancer immunotherapy: the rise of chimeric antigen receptor macrophage (CAR-M)
Jing, J., Chen, Y., Chi, E., Li, S., He, Y., Wang, B., Shen, H., Fan, L., Wang, J., Shangguan, T., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07115-9 · Cited by 27
“Within this environment, macrophages exhibit remarkable plasticity, dynamically adjusting their transcriptional profiles and functions in response to environmental, tissue-specific, and inflammatory stimuli [89, 90].”
Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
Zaher, A., Stephens, L. M., Miller, A. M., Hartwig, S. M., Stolwijk, J. M., Petronek, M. S., Zacharias, Z. R., Wadas, T. J., Monga, V., Cullen, J. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.989000 · Cited by 26
Gu, L., Feng, C., Li, M., Hong, Z., Di, W. J., & Qiu, L. (2023) · European journal of medical research · doi:10.1186/s40001-023-01246-9 · Cited by 25
“However, M2-type macrophages have low antigen presenting ability and low anti-tumor activity, which are beneficial for tumor growth and invasion [17].”
BackgroundYeast glucan particles: An express train for oral targeted drug delivery systems
Yang, F., Shang, S., Qi, M., Xiang, Y., Wang, L., Wang, X., Lin, T., Hao, D., Chen, J., Liu, J., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127131 · Cited by 28
Cytokine‐Induced Memory‐Like NK Cells: Emerging strategy for AML immunotherapy
Bakhtiyaridovvombaygi, M., Yazdanparast, S., Mikanik, F., Izadpanah, A., Parkhideh, S., Ghasabeh, A. S., Roshandel, E., Hajifathali, A., & Gharehbaghian, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115718 · Cited by 28
Zhang, Y., Ding, X., Zhang, X., Li, Y., Xu, R. C., Li, H., Zuo, D., & Chen, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1404687 · Cited by 33
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review
Hosseini, T. M., Park, S. J., & Guo, T. W. (2024) · Cancers · doi:10.3390/cancers16162904 · Cited by 27
“While more recent research suggests that TAMs are not strictly adherent to M1/M2 states and can be alternatively defined based on their effect on the TME as either pro-or anti-inflammatory [152], most studies on cSCC have focused on traditional M1/M2 classifications.”
BackgroundSiglecs as modulators of macrophage phenotype and function.
Kukan, E., Fabiano, G. L., & Cobb, B. A. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101887 · Cited by 24
Xiao, S., Xu, R. Y., Yang, Y., Zhao, R., Xie, Y., Lei, X.-D., & Wu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1431535 · Cited by 26
Park, H.-J., Lee, S.-C., & Park, S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151087 · Cited by 30
Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy
Jin, H., Meng, X., & Feng, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1560393 · Cited by 34
“Commonly, they are categorized into two major phenotypes: classically activated M1 and alternatively activated M2 (21 – 23).”
Yan, Y., Lu, J., Luo, H., Wang, Z., Xu, K., Wang, L., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1667464 · Cited by 29
Accumulation of Intracellular Ferrous Iron in Inflammatory-Activated Macrophages
Ma, H., Shu, Q., Li, D., Wang, T., Li, L., Song, X., Lou, K., & Xu, H. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03362-9 · Cited by 26
“Emerging evidences demonstrated that macrophages were extremely heterogeneous and plastic cells, which could be divided into different populations depended on the polarizations [1].”
BackgroundLi, C., Wu, C., Ji, C., Xu, G., Chen, J., Zhang, J., Hong, H., Liu, Y., & Cui, Z. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1132015 · Cited by 24
“Macrophage polarization is unstable and may be affected by various factors (Boutilier and Elsawa, 2021).”
BackgroundLv, K., Sun, M., Fang, H., Wang, J., Lin, C., Liu, H., Zhang, H., Li, H., He, H., Gu, Y., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007669 · Cited by 26
Liu, Y., Chen, X., Xu, Y., Yang, T., Wang, H., Wang, Z., Hu, Z., Chen, L., Zhang, Z., & Wu, Y. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02399-0 · Cited by 27
“Previous studies have shown that the M2 macrophages could stimulate angiogenesis and enhance tumor cell invasion and motility [10].”
Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention
Laeeq, T., Ahmed, M., Sattar, H., Zeeshan, M. H., & Ali, M. B. (2024) · Cancers · doi:10.3390/cancers16071325 · Cited by 24
“M2 macrophages contribute to tumor cell metastasis and proliferation through their anti-inflammatory mechanisms [45].”
BackgroundReprogramming of breast tumor–associated macrophages with modulation of arginine metabolism
Fernando, V., Zheng, X., Sharma, V., Sweef, O., Choi, E. S., & Furuta, S. (2024) · Life Science Alliance · doi:10.26508/lsa.202302339 · Cited by 27
“Conversely, the increased M1/M2-TAM ratio improves the tumor prognosis and therapeutic response (13, 14, 15).”
BackgroundThe tumor microenvironment's gambit: Exosomal pawns on the board of head and neck cancer
Mohamadi, S., Mehrasa, P., Mehramuz, B., Kobravi, S., Taghizadieh, M., Salmaninejad, A., Bayat, M., & Nahand, J. S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189189 · Cited by 30
The RAGE/multiligand axis: a new actor in tumor biology
Rojas, A., Schneider, I., Lindner, C., González, I., & Morales, M. A. (2022) · Bioscience Reports · doi:10.1042/bsr20220395 · Cited by 25
“, Molls, M. and Radons, J. (2012) Chronic inflammation in cancer development.”
BackgroundZha, C., Yang, X., Yang, J., Zhang, Y., & Huang, R. (2024) · Annals of Hematology · doi:10.1007/s00277-024-06117-9 · Cited by 24
“M2 macrophages are known for their reduced production of inflammatory cytokines, increased secretion of anti-inflammatory cytokines, and promotion of angiogenesis [24, 25].”
Zhang, S., Chen, J., Cheng, F., & Fang, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413722 · Cited by 25
Yin, J., Yang, L., Liu, Y., Shi, Q., Shi, M., Zhu, Z., Fu, D., Wang, Z., & Li, C. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010162 · Cited by 25
“11 13 Consequently, M2 macrophages significantly contribute to tumor growth.”
The role of the tumor microenvironment in HNSCC resistance and targeted therapy
Guo, Z., Li, K., Ren, X., Wang, X., Yang, D., Ma, S., Zeng, X., & Zhang, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1554835 · Cited by 25
“TAMs secrete various cytokines, including TGF-b and IL-6, which facilitate tumor-promoting activities and immune suppression within the TME (22).”
The dynamic roles of macrophages extracellular traps (METs) in immune regulation
Shin, Y., Bae, H., Lee, C., & Rhee, I. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01540-6 · Cited by 25
“Importantly, macrophages can shift between the M1 and M2 states depending on the local microenvironment, demonstrating their functional plasticity (Boutilier et al. 2021).”
Zhao, F., Yue, Z., Zhang, L., Qi, Y., Sun, Y., Wang, S., & Tian, Q. (2025) · Journal of Innate Immunity · doi:10.1159/000546476 · Cited by 25
“An elevated M1/M2 ratio suggests an inhibition of tumor development, while a reduced ratio indicates enhanced tumor invasion and metastasis [90].”
Pavlov, S., Ali, E., Ambrozkiewicz, F., Ye, W., Rajtmajerová, M., Liška, V., Hemminki, K., & Trailin, A. (2025) · Journal of Cancer · doi:10.7150/jca.126772 · Cited by 27
“Accordingly, it is important to investigate the biological functions of specific macrophage molecules, their expression levels, and potential co-expression with other markers to better characterize the effects of TAMs [10, 11].”
Lin, M., Ma, S., Sun, L., & Qin, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1094400 · Cited by 28
Wang, T., Yu, M., Li, H., Qin, S., Ren, W., Ma, Y., Bo, W., Xi, Y., Cai, M., & Tian, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044159 · Cited by 24
“Mannose receptor (CD206) and arginase-1 (Arg1) were viewed as markers of M2 macrophage [32].”
BackgroundGu, J., Yang, S., Wang, X., Wu, Y., Wei, J., & Xu, J. (2023) · Cancer Medicine · doi:10.1002/cam4.5954 · Cited by 24
Brauneck, F., Oliveira‐Ferrer, L., Muschhammer, J., Sturmheit, T., Ackermann, C., Haag, F., Wiesch, J. S. Z., Ding, Y., Qi, M., Hell, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1250258 · Cited by 25
“Especially for TAMs, different phenotypes could be found depending on the external stimuli of the tumor microenvironment (27, 28).”
BackgroundGanguly, K., Luthfikasari, R., Randhawa, A., Dutta, S. D., Patil, T. V., Acharya, R., & Lim, K. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400581 · Cited by 23
Xu, L., Zhao, R., Yu, B., Huo, R., Xue, G., & Wu, J. (2024) · Genomics · doi:10.1016/j.ygeno.2024.110914 · Cited by 25
Su, P., Tian, Y., Zhang, Y., Huang, H., Chen, M., Cao, C., Kang, W., Liu, Y., & Yu, J. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03453-8 · Cited by 24
“Accumulating evidence indicated that tumor associated macrophages (TAMs), especially those exhibiting alternative activation (M2 phenotype), play a significant role in dedicating tumor chemoresistance [20, 30].”
BackgroundManipulating immune activity of macrophages: a materials and mechanics perspective
Clevenger, A. J., Jha, A., Moore, E., & Raghavan, S. A. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.07.009 · Cited by 23
Cheng, Y., Han, X., Lai, X., & Wei, X. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156093 · Cited by 25
Xu, F., Yan, J., Peng, Z., Liu, J., & Li, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1096009 · Cited by 22
“Hypoxia is strongly correlated with poor prognosis, with its pathway activated throughout cancer advancement (33).”
BackgroundThe Adipocyte–Macrophage Relationship in Cancer: A Potential Target for Antioxidant Therapy
Sanhueza, S., Simón, L., Cifuentes, M., & Quest, A. F. G. (2023) · Antioxidants · doi:10.3390/antiox12010126 · Cited by 24
Rynikova, M., Adamkova, P., Hradická, P., Štofilová, J., Harvanová, D., Matejová, J., & Demečková, V. (2023) · Biomedicines · doi:10.3390/biomedicines11020608 · Cited by 23
“Moreover, they play a key part in tissue regeneration, wound healing, and clearance of old cells and debris [29,30].”
BackgroundAdvanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy
Chen, W., Li, C., & Jiang, X. (2023) · Small Methods · doi:10.1002/smtd.202201404 · Cited by 23
Li, X., Du, Y., Jiang, W., Dong, S., Li, W., Tang, H., Yi, J., Zhou, W., & Zhang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1170223 · Cited by 27
“Macrophages can induce tumor cell proliferation and metastasis through angiogenesis, immunosuppression, hypoxia induction and other pathways and are involved in many tumor-promoting outcomes in cancer (24).”
BackgroundGe, S., Sun, X., Sang, L., Zhang, M., Yan, X., Ju, Q., Ma, X., & Xu, M. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14330 · Cited by 24
“The presence of M2-like TAM is related to its tumor-promoting activity, while the presence of M1-like TAM is related to antitumor activity (Boutilier & Elsawa, 2021).”
Chatterjee, O., & Sur, D. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176006 · Cited by 22
Factors impacting the benefits and pathogenicity of Th17 cells in the tumor microenvironment
Xing, J., Man, C., Liu, Y., Zhang, Z., & Peng, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224269 · Cited by 29
Alveolar macrophages in lung cancer: opportunities and challenges
Chang, C.-Y., Armstrong, D., Corry, D. B., & Kheradmand, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1268939 · Cited by 30
“Tumor cells can further recruit and polarize monocytes accelerating growth/angiogenic factor production, increasing proteinases, and facilitating tumor invasion, suggesting co-evolution between these two cell types (18).”
BackgroundWang, M., Li, Y., Li, S., Wang, T., Wang, M., Wu, H., Zhang, M., Luo, S., Zhao, C., Li, Q., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117472 · Cited by 24
Macrophage plasticity and function in cancer and pregnancy
Yin, T., Li, X., Li, Y., Zang, X., Liu, L., & Du, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1333549 · Cited by 24
“…TLR or IL-1R agonists) exert immunoregulatory functions and drive Th2 responses, whereas M2c macrophages (induced by IL-10) are more related to anti-in fl ammatory activities against apoptotic cells and M2d macrophages (induced by TLR antagonists) are inclined to induce tumor progression (33, 34).”
BackgroundSullivan, K. M., Li, H., Yang, A., Zhang, Z., Muñoz, R. M., Mahuron, K. M., Yuan, Y., Paz, I. B., Hoff, D. D. V., Han, H., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074117 · Cited by 24
“Rather, macrophages exist along a dynamic polarizing spectrum that exhibits plasticity from one phenotype to another [17,18].”
BackgroundTMEM205 induces TAM/M2 polarization to promote cisplatin resistance in gastric cancer
Fu, Q., Wu, X., Lu, Z., Chang, Y., Jin, Q., Jin, T., & Zhang, M. (2024) · Gastric Cancer · doi:10.1007/s10120-024-01517-2 · Cited by 26
“Our results showed that TMEM205 promoted the proliferation, stemness, migration, and angiogenesis of SGC-7901/DDP cells by inducing the EMT process, thereby accelerating the malignant progress of GC. TAMs involved in cancer proliferation, migration, invasion, and chemoresistance [52].”
BackgroundYang, C., Bao, S., Wang, Z., Fang, Z., & Tang, H. (2024) · European journal of medical research · doi:10.1186/s40001-024-01930-4 · Cited by 23
“M1-like macrophages initially functioned in the TME to suppress cancer cell growth [49].”
BackgroundRecent Advances in Immunotherapy for Breast Cancer: A Review
Wen, Q.-E., Li, L., Feng, R.-Q., Li, D., Qiao, C., Xu, X., & Zhang, Y.-J. (2024) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s482504 · Cited by 28
“21,22 Tumor immune evasion The human body’s immune system is a dynamic developmental process that involves immune monitoring, tumor immunoe-diting, and the identification and removal of new cancers.”
BackgroundChen, S. M. Y., Popolizio, V., Woolaver, R. A., Ge, H., Krinsky, A. L., John, J., Danis, E. P., Ke, Y., Kramer, Y., Li, B., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02337-x · Cited by 23
“Keywords: Cancer immunotherapy, Head and neck cancers, Immune tumor microenvironment, Tumor infiltrating lymphocytes, p53 mutations, PIK3CA hyperactivation IL-10 and TGF-β, and chemokine CCL17 and CCL22 [29].”
BackgroundExosomes: efficient macrophage-related immunomodulators in chronic lung diseases
Kang, J., Hua, P., Wu, X., & Wang, B. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1271684 · Cited by 22
“The contradictory nature of these roles primarily depends on the speci fi c functions of macrophages at different disease stages and their interactions with other immune cells and in fl ammatory mediators (Boutilier and Elsawa, 2021; Lee et al., 2021; Basak et al., 2023).”
BackgroundGao, H., Shi, L., Liu, J., Zhao, Y., Du, F., He, Y., Yang, X., Song, N., Wen, J., & Zheng, G. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05170-2 · Cited by 24
“The role of M2-polarized macrophages in contributing to pro-tumorigenic outcomes has been proved in recent years [23].”
Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis
Yamamoto-Furusho, J. K., & Gutierrez-Herrera, F. D. (2025) · Cells · doi:10.3390/cells14030162 · Cited by 27
“…among others, resulting in anti-tumoral, anti-microbial, and proinflammatory effects, while resident macrophages are activated by the Th2 cytokines IL-10 and IL–4, as M2 that display a strong phagocytic capability and promote angiogenesis, tissue repair, and the suppression of immune response [65].”
Advances in tumor-associated macrophage-mediated chemotherapeutic resistance in glioma
Liu, X., & Yu, Q. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1676338 · Cited by 25
Potential PET tracers for imaging of tumor-associated macrophages
Fernandes, B., Feltes, P. K., Luft, C., Nazario, L. R., Jeckel, C. M. M., Antunes, I. F., Elsinga, P. H., & de Vries, E. F. J. (2022) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-022-00163-2 · Cited by 24
“In contrast, tumors in more advanced stages mainly contain macrophages of the M2 phenotype, which induce a pro-tumoral state (tumor progression) (Boutilier and Elsawa 2021).”
BackgroundInfluentialThe tumor immune microenvironment in peritoneal carcinomatosis
Demuytere, J., Ernst, S., van Ovost, J., Cosyns, S., & Ceelen, W. P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.015 · Cited by 23
Ding, Y., Xue, M., Tang, Q., Wang, L., Ding, H.-Y., Li, H., Gao, C., & Yu, W. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i37.5403 · Cited by 22
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms
Guo, H., Yang, J., Wang, H., Liu, X., Liu, Y., & Zhou, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1017990 · Cited by 22
Ma, M., Liu, X., Ma, C., Guo, R., Zhang, X., Zhang, Z., & Ren, X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.242 · Cited by 22
Pediatric Brain Tumours: Lessons from the Immune Microenvironment
Yao, B., Delaidelli, A., Vogel, H. S., & Sorensen, P. H. B. (2023) · Current Oncology · doi:10.3390/curroncol30050379 · Cited by 21
Dossou, A. S., Mantsch, M. E., Kapic, A., Burnett, W. L., Sabnis, N. A., Coffer, J. L., Berg, R. E., Fudala, R., & Lacko, A. G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061685 · Cited by 23
Liu, F., Yuan, D., Liu, X., Zhuo, S., Liu, X., Sheng, H., Sha, M., Ye, J., & Yu, H. (2023) · Discover Oncology · doi:10.1007/s12672-023-00711-5 · Cited by 21
“Overall, an in-depth understanding of TME status in ESCC patients helps to elucidate their genomic profile and improve prognosis.”
BackgroundInfluentialXia, B., Liu, Y., Wang, J., Lu, Q., Lv, X., Deng, K., & Yang, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106880 · Cited by 21
Zhou, Y. L., Dong, Y., Zhang, A., Wu, J., & Sun, Q. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1214190 · Cited by 22
“In addition, some are already in clinical trials, such as Amikacin liposomes (BeltránGracia et al., 2019; Boutilier and Elsawa, 2021).”
BackgroundSubverted macrophages in the triple-negative breast cancer ecosystem
Shang, L., Zhong, Y., Yao, Y., Liu, C., Wang, L., Zhang, W., Liu, J., Wang, X., & Sun, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115414 · Cited by 23
Singh, K., & Gautam, P. K. (2023) · BMC Cancer · doi:10.1186/s12885-023-11674-9 · Cited by 22
“In early stage of cancer, the number of pro-inflammatory M1 macrophages is higher than anti-inflammatory M2 macrophages [20].”
BackgroundHan, H., He, T., Wu, Y., He, T., & Zhou, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1441081 · Cited by 23
“Polarization imbalance of tumor-associated macrophages (TAMs) in the tumor microenvironment, particularly the accumulation of M2-type TAMs, plays a signi fi cant role in cancer progression (Boutilier and Elsawa, 2021).”
BackgroundLi, F., Zeng, C., Liu, J., Wang, L., Yuan, X., Li, Y., Xia, X., & Huang, W. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1784 · Cited by 21
“125 Macrophages lacking in METTL14 or YTHDF1 cause septic mice models via CLP or lipopolysaccharide (LPS), which results in increased levels of proinflammatory cytokines and chemokines.”
BackgroundSharma, A., Vikramdeo, K. S., Sudan, S. K., Anand, S., Deshmukh, S. K., Singh, A. P., & Singh, S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107753 · Cited by 21
“The M1 and M2 macrophage polarization markers were used in line with the established literature (7, 21 – 25).”
BackgroundMethodZhang, Z., Ye, P., Dang, J., Liu, X., Zhu, D., Zhang, Y., Shi, Y., & Fan, H. (2022) · Oral Diseases · doi:10.1111/odi.14173 · Cited by 21
Yang, L., Xiong, L., & He, X. (2025) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.5c00016 · Cited by 23
The role of SPP1 + TAMs in cancer: Impact on patient prognosis and future therapeutic targets
Li, X., Lian, J., & Lu, H. (2025) · International Journal of Cancer · doi:10.1002/ijc.70018 · Cited by 21
“7 – 10 Given their role in promoting tumor progression and metastasis via multiple mechanisms, TAMs are increasingly being explored as potential therapeutic targets in cancer.”
The immune microenvironment of pathogen-associated cancers and current clinical therapeutics
Wei, X., Feng, H., Zhu, Y.-Y., Guo, S.-J., Wang, H., Li, M., & Mei, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02448-x · Cited by 23
“The polarization of macrophages in the tumor micro-environment is nuanced [16, 17]; hence, the immune outcome is determined in pathogen-associated cancers by the functional polarization of macrophages.”
Fu, X., Pang, M., Wang, Z., & Wang, H. (2025) · Cancer Control · doi:10.1177/10732748251406674 · Cited by 23
Exploring hypoxic biology to improve radiotherapy outcomes
Li, C., Wiseman, L., Okoh, E., Lind, M., Roy, R., Beavis, A. W., & Pires, I. M. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.14 · Cited by 25
Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages
Santos, M. A. R. D. C., dos Reis, J. S., Santos, C. A. D. N., da Costa, K. M., Barcelos, P. M., Francisco, K. Q. D. O., Barbosa, P. A. G. N., da Silva, E. D. S., Freire-de-Lima, C. G., Morrot, A., et al. (2022) · Immunologic Research · doi:10.1007/s12026-022-09321-9 · Cited by 20
Cellular milieu in clear cell renal cell carcinoma
Raghubar, A. M., Roberts, M. J., Wood, S., Healy, H. G., Kassianos, A. J., & Mallett, A. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.943583 · Cited by 25
“Recruited monocytes enter the kidney tissue and differentiate to macrophages, activating the innate immune response through phagocytosis, exogenous antigen presentation, and immunomodulation (34).”
BackgroundSri-ngern-ngam, K., Keawvilai, P., Pisitkun, T., & Palaga, T. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101369 · Cited by 22
“However, lacking PD-1 in THP-1 cell line significantly reduced polarization capability toward M2 state after stimulation with IL-4 using CD163, one of M2 marker, which was consistent with previous reports [9,36].”
ResultDevelopmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2
Chen, K., Gong, W., Huang, J., Yoshimura, T., & Wang, J. M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110052 · Cited by 21
MSC−sEV Treatment Polarizes Pro−Fibrotic M2 Macrophages without Exacerbating Liver Fibrosis in NASH
Zhang, B., Zhang, B., Lai, R. C., Sim, W. K., Lam, K., & Lim, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098092 · Cited by 20
“While our MSC−sEV preparations have shown promising results in improving outcomes in osteochondral repair [23,24] and survival of allogeneic skin graft in mice [17], they could potentially aggravate other diseases and may exacerbate disease progression or contribute to tissue damage such as promoting tumor growth and…”
ResultMolecular mechanisms of microRNA-301a during tumor progression and metastasis
Shad, A. N., Fanoodi, A., Maharati, A., Akhlaghipour, I., & Moghbeli, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154538 · Cited by 22
Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment
Azimnasab-sorkhabi, P., Soltani-asl, M., Yoshinaga, T. T., Dagli, M. L., Massoco, C. D. O., & Kfoury, J. R. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08469-3 · Cited by 22
Zhou, C., Huang, Y., Da, M., Jin, W., & Zhou, F. (2023) · Discover Oncology · doi:10.1007/s12672-023-00704-4 · Cited by 22
“It’s crucial to remember that Tumor-associated macrophages (TAMs) behave similarly to M2 macrophages in the tumor microenvironment [147].”
BackgroundLiver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
Kaps, L., Limeres, M. J., Schneider, P. M., Svensson, M., Zeyn, Y., Ghazi, S. F.-E., Cacicedo, M. L., Galle, P. R., Gehring, S., & Bros, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411869 · Cited by 24
“In a TAM-focused approach, Wang and coworkers [162] demonstrated the synergistic anti-tumor effects of sorafenib-loaded cationic lipid (L)NPs for direct HCC killing and coapplied cationic LNPs coated with mannose for TAM targeting that were loaded with the nuclear factor kappa-light-chain-enhancer of activated B-cells…”
BackgroundTang, Q., Zhang, F., Luo, L., Duan, Y., Zhu, T., Ni, Y., Wang, Y., Qi, H., Jiang, S., Zhou, J., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12599 · Cited by 20
Biomarkers and experimental models for cancer immunology investigation
Xu, H., Jia, Z., Liu, F., Li, J., Huang, Y., Jiang, Y., Pu, P., Shang, T., Tang, P., Zhou, Y., et al. (2023) · MedComm · doi:10.1002/mco2.437 · Cited by 24
“298,299 Direct interaction is divided into simple and complex interactions.”
BackgroundImmune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas
Jumaniyazova, E. D., Lokhonina, А. V., Dzhalilova, D. S., Kosyreva, A. M., & Fatkhudinov, T. (2023) · Cancers · doi:10.3390/cancers15245760 · Cited by 25
“…are implicated in angiogenesis and lymphangiogenesis, which provide the structural basis for tumor advancement and metastasis [25,26] and are considered to be putative therapeutic targets in STSs. Macrophage polarization is induced by cytokines and chemokines produced by other immune cells [27,28].”
BackgroundWang, H., Liu, S., Zhan, J., Liang, Y., & Zeng, X. (2024) · International Journal of Cancer · doi:10.1002/ijc.34921 · Cited by 20
“49 Recent studies have highlighted the role of exosomes secreted by tumor cells in regulating TAMs.”
BackgroundZeng, Y.-Y., Gu, Q., Li, D., Li, A.-X., Liu, R., Liang, J., & Liu, J. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01355-z · Cited by 25
“Furthermore, endotoxins and TNF-α induce monocytes to differentiate into the M1 phenotype [127].”
Tang, C., & Zhang, Y. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155518 · Cited by 20
Sun, Z., Zhang, F., Gao, Z., Wu, J., Bi, Q., Zheng, X., Zhang, J., Cao, P., & Wang, W. J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113258 · Cited by 22
Choi, J. Y., Seok, H. J., Lee, D. H., Kwon, J., Shin, U. S., Shin, I., & Bae, I. H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05797-1 · Cited by 23
“M2 macrophages display a pro-tumor phenotype and are involved in EMT, angiogenesis and metastasis [14].”
BackgroundImpact of Modern Lifestyle on Circadian Health and Its Contribution to Adipogenesis and Cancer Risk
Dobrovinskaya, O. R., Alamilla, J., & Olivas-Aguirre, M. (2024) · Cancers · doi:10.3390/cancers16213706 · Cited by 26
Baron, M., Drohat, P., Crawford, B., Hornicek, F. J., Best, T. M., & Kouroupis, D. (2023) · Bioengineering · doi:10.3390/bioengineering10101187 · Cited by 19
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21–23].”
BackgroundItraconazole inhibits tumor growth via CEBPB‐mediated glycolysis in colorectal cancer
Zhang, Y., Li, L., Chu, F., Wu, H., Xiao, X., Ye, J., & Li, K. (2024) · Cancer Science · doi:10.1111/cas.16082 · Cited by 19
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.